Moreover, PBRM1MUT ccRCC tumors are associated with lower immunoscores (P=0.001) and ESTIMATES scores (P=0.007; Figure 2C), indicated PBRM1 mutation predicted worse response to PD-1 blockade. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.